Phospho-STAT5A/STAT5B (S726/731) Antibody

What is the molecular specificity of Phospho-STAT5A/STAT5B (S726/731) Antibody?

Phospho-STAT5A/STAT5B (S726/731) antibodies specifically detect endogenous levels of STAT5A protein only when phosphorylated at Ser726, and STAT5B protein only when phosphorylated at Ser731. The specificity has been rigorously validated through mutant analysis studies, where no detectable band was observed for the S731A STAT5b mutant in Western blot analyses . This confirms that these antibodies recognize only the phosphorylated form of the protein at these specific serine residues.

The antibody's specificity is critical for distinguishing between the non-phosphorylated and phosphorylated forms of STAT5A/B, which is essential for studying the activation status of these transcription factors in various signaling pathways. Most commercially available antibodies are polyclonal, though some recombinant monoclonal options are also available .

What applications have been validated for Phospho-STAT5A/STAT5B (S726/731) Antibodies?

The applications for Phospho-STAT5A/STAT5B (S726/731) antibodies have been extensively validated across multiple experimental platforms:

Researchers should note that optimal conditions may vary between different antibody products and experimental systems. It is recommended to titrate the antibody in each testing system to determine optimal working concentrations .

How does EGF stimulation affect Ser726/Ser731 phosphorylation dynamics?

EGF (Epidermal Growth Factor) stimulation significantly enhances Ser731 phosphorylation of STAT5B, with distinct temporal dynamics. Research using the human breast cancer cell line SKBr3 has demonstrated that:

• Basal levels of S731 phosphorylation are detectable even without stimulation

• EGF treatment rapidly increases S731 phosphorylation within 5 minutes

• This phosphorylation is sustained for up to 3 hours (180 minutes) before gradually decreasing

• The serine phosphorylation occurs in parallel with tyrosine (Y699) phosphorylation

This represents the first documented evidence of EGF-stimulated S731 phosphorylation in the transactivation domain of STAT5B, particularly in breast cancer cells that overexpress EGFR and HER2 tyrosine kinases. The simultaneous phosphorylation of both serine and tyrosine residues suggests coordinated regulation of STAT5 activity through multiple phosphorylation events .

What is the functional relationship between tyrosine and serine phosphorylation in STAT5A/B?

The interplay between tyrosine phosphorylation (Y694/Y699) and serine phosphorylation (S726/S731) in STAT5A/B represents a complex regulatory mechanism:

• Y694 (STAT5A) and Y699 (STAT5B) phosphorylation is required for dimerization, nuclear translocation, and DNA binding

• S726 (STAT5A) and S731 (STAT5B) phosphorylation in the transactivation domain modulates transcriptional activity

• Studies with STAT5B mutants reveal a functional interdependence between these sites:

  • The Y740/743F STAT5B mutant shows increased basal Y699 phosphorylation

  • This mutant also exhibits increased S731 phosphorylation

  • When S731 is mutated to alanine in this context (S731A/Y740/743F), the increased Y699 phosphorylation is abrogated

These findings indicate that S731 phosphorylation is necessary for the increased Y699 phosphorylation observed in the Y740/743F mutant, suggesting a regulatory circuit where serine phosphorylation influences tyrosine phosphorylation and vice versa . This complex interplay between different phosphorylation sites is crucial for fine-tuning STAT5 activity in response to various cellular signals.

How does serine phosphorylation affect STAT5 transcriptional activity?

Serine phosphorylation significantly impacts STAT5 transcriptional activity, particularly in specific mutant contexts. Research using luciferase reporter assays with STAT5-specific response elements (Spi2.1-luciferase) has revealed:

These data demonstrate that while S731 phosphorylation has limited impact on wild-type STAT5B function, it is essential for the enhanced transcriptional activity observed in the Y740/743F mutant . This context-dependent effect highlights the complex regulation of STAT5 activity through multiple phosphorylation sites.

What biological processes are regulated by S726/S731 phosphorylation?

S726/S731 phosphorylation of STAT5A/B influences several critical biological processes:

• DNA Synthesis and Cell Proliferation:

  • The Y740/743F STAT5B mutant significantly increases basal DNA synthesis as measured by BrdU incorporation

  • This enhanced proliferative effect is completely dependent on S731, as the S731A/Y740/743F double mutant decreases DNA synthesis below wild-type levels

• Transcriptional Regulation:

  • S731 phosphorylation modulates STAT5B's ability to activate target genes

  • This affects expression of genes involved in cell survival, proliferation, and differentiation

• Cancer Cell Biology:

  • In breast cancer cells, the enhanced activity of STAT5 mutants requiring S731 phosphorylation suggests a role in cancer progression

  • Understanding S731 phosphorylation provides potential therapeutic targets for cancers with aberrant STAT5 signaling

These findings establish S726/S731 as critical regulatory sites that influence STAT5's biological functions, particularly in the context of cancer cell proliferation and transcriptional regulation .

What methods can verify antibody specificity for phosphorylated STAT5A/B?

Validating the specificity of phospho-STAT5A/B antibodies requires multiple complementary approaches:

• Peptide Competition Assay:

  • Compare antibody reactivity between phosphorylated and non-phosphorylated peptides

  • As demonstrated in multiple studies, the antibody should only recognize the phosphorylated form

• Mutant Analysis:

  • Test antibody reactivity against S726A STAT5A or S731A STAT5B mutants

  • The antibody should not recognize these mutants if it is specific for the phosphorylated serine

• Cellular Stimulation:

  • Compare antibody signal between unstimulated cells and cells treated with stimuli known to induce STAT5 phosphorylation (e.g., GM-CSF, EGF)

  • A specific increase in signal should be observed in stimulated cells

• Phosphatase Treatment:

  • Treat lysates with phosphatase enzymes to remove phosphorylation

  • Signal should be lost after phosphatase treatment if the antibody is phospho-specific

• Inhibitor Studies:

  • Treat cells with STAT5 inhibitors that block phosphorylation

  • Signal should decrease in inhibitor-treated samples

When applying these validation methods, researchers should use appropriate positive controls such as GM-CSF-treated TF-1 cells, which exhibit robust STAT5 phosphorylation .

What signaling pathways regulate STAT5A/B S726/S731 phosphorylation?

Multiple signaling pathways regulate STAT5A/B S726/S731 phosphorylation through complex networks:

• Growth Factor Signaling:

  • EGF stimulation enhances S731 phosphorylation of STAT5B in breast cancer cells

  • The human epidermal growth factor (hEGF) induces STAT5 phosphorylation at Y694, which may cross-regulate serine phosphorylation

• Cytokine Signaling:

  • IL-2, IL-3, IL-7, GM-CSF, erythropoietin, and thrombopoietin activate STAT5 and may regulate serine phosphorylation

  • Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple STAT5 isoforms

• Serine/Threonine Kinase Pathways:

  • Calyculin A, a phosphatase inhibitor, increases S726/S731 phosphorylation, suggesting regulation by serine/threonine phosphatases

  • Treatment of TF-1 cells with 100 nM Calyculin A for 30 minutes enhances S726/S731 phosphorylation

• Cross-regulation with Other Phosphorylation Sites:

  • The Y740/743F STAT5B mutant shows increased S731 phosphorylation, indicating regulatory interplay between different phosphorylation sites

  • STAT5 inhibitors that specifically block Y694 phosphorylation may indirectly affect serine phosphorylation patterns

Understanding these regulatory pathways is crucial for developing therapeutic strategies targeting STAT5 signaling in diseases like cancer .

How can Phospho-STAT5A/B antibodies be used to study STAT5 oligomer formation?

STAT5 proteins can form various oligomeric structures with distinct functional properties. Phospho-STAT5A/B antibodies can be employed to investigate these complexes through several approaches:

• Native Gel Electrophoresis:

  • Use non-denaturing conditions to preserve protein-protein interactions

  • Separate STAT5 monomers, dimers, and tetramers based on size and charge

  • Transfer to membrane and probe with phospho-specific antibodies

  • Compare patterns between stimulated and unstimulated samples

• Co-immunoprecipitation:

  • Immunoprecipitate with anti-STAT5 antibody

  • Probe with Phospho-STAT5A/STAT5B (S726/S731) antibody

  • Analyze the presence of differentially phosphorylated STAT5 species in the complexes

• Chromatin Immunoprecipitation (ChIP):

  • Use the antibody to study recruitment of phosphorylated STAT5 to DNA

  • Focus on promoters with multiple STAT5 binding sites that support tetramer formation

  • Compare phosphorylation status at single versus paired STAT5 binding sites

Research has shown that leukemic patient samples display an increased abundance of STAT5 tetramer complexes compared to controls. These complexes showed distinct migration patterns on native gels, suggesting the involvement of different post-translational modifications including phosphorylation . Using phospho-specific antibodies like Phospho-STAT5A/STAT5B (S726/S731) can help determine if serine phosphorylation influences oligomer formation or stability.

What are optimal storage and handling conditions for Phospho-STAT5A/B antibodies?

Proper storage and handling are essential for maintaining antibody performance:

For optimal results, researchers should:

• Check the specific storage requirements for their particular antibody product

• Keep track of the number of freeze-thaw cycles

• Follow the manufacturer's recommendations for handling and dilution

• Be aware that sodium azide in the storage buffer is highly toxic

What troubleshooting approaches are recommended for inconsistent antibody performance?

When troubleshooting inconsistent performance with Phospho-STAT5A/B antibodies, consider these methodological approaches:

• Sample Preparation Issues:

  • Ensure complete phosphatase inhibition during lysis to preserve phosphorylation status

  • Use fresh samples or properly stored frozen samples to maintain protein integrity

  • Confirm protein concentration is consistent between samples

• Antibody Dilution Optimization:

  • Test multiple dilutions to find the optimal concentration

  • For Western blot, try a range from 1:500-1:50,000 depending on the specific product

  • For immunofluorescence, a range of 1:200-1:800 is typically recommended

• Control Implementation:

  • Include positive controls such as GM-CSF-treated TF-1 cells

  • Use negative controls including unstimulated cells or phosphatase-treated samples

  • Consider phospho-blocking peptide competition controls

• Protocol Modification:

  • Optimize blocking conditions (type of blocking agent, time, concentration)

  • Adjust antibody incubation time and temperature

  • Increase washing stringency to reduce background

  • For Western blot, try different membrane types or transfer conditions

• Reagent Quality Assessment:

  • Check antibody expiration date and storage conditions

  • Prepare fresh buffers and reagents

  • Validate stimulation conditions to ensure effective STAT5 phosphorylation

When experimental results differ from published data, consider biological variations in phosphorylation levels between different cell types, treatments, and experimental conditions.

How do STAT5A and STAT5B differ in their phosphorylation patterns and functions?

Despite 90% sequence identity, STAT5A and STAT5B exhibit distinct phosphorylation patterns and functional roles:

While both proteins respond to similar stimuli, research suggests they have partially non-redundant functions:

• STAT5A plays a more prominent role in mammary gland development and lactation

• STAT5B is more critical for growth hormone-mediated body growth regulation

• Both are implicated in cancer progression, particularly in leukemia, prostate, and breast cancer

Understanding these distinctions is crucial when designing experiments targeting specific STAT5 isoforms and interpreting research results .

What is the significance of S726/S731 phosphorylation in cancer research?

The phosphorylation of STAT5A at S726 and STAT5B at S731 has significant implications for cancer research:

• Altered STAT5 Signaling in Cancer:

  • The JAK2-STAT5A/B signaling pathway is involved in the transition of organ-confined prostate cancer to hormone-refractory disease

  • Aberrant STAT5 activation has been implicated in the pathogenesis of chronic myelogenous leukemia, prostate cancer, breast cancer, and tumor metastasis

• Therapeutic Target Potential:

  • Understanding S726/S731 phosphorylation provides potential targets for pharmacological intervention

  • Three different STAT5 inhibitors (573108, AC-3-19, and AC-4-130) that specifically inhibit STAT5 phosphorylation at Y694 have shown promise in research settings

  • Modulating serine phosphorylation could represent a novel approach to targeting STAT5 activity

• Diagnostic and Prognostic Value:

  • Analysis of patient samples has shown altered STAT5 phosphorylation patterns in leukemia

  • Leukemic patient samples displayed an increased abundance of STAT5 tetramer complexes

  • Phosphorylation status may serve as a biomarker for disease progression or treatment response

• Mechanistic Insights:

  • S731 is required for the increased DNA synthesis seen with the Y740/743F STAT5B mutant

  • This suggests that targeting serine phosphorylation could potentially inhibit cancer cell proliferation

  • The sites in the transactivation domain of STAT5B (S731, Y740, Y743) provide targets to mechanistically modulate STAT5b function in breast cancer cells

These findings highlight the importance of studying S726/S731 phosphorylation for developing novel cancer therapeutics and diagnostic tools .

How can researchers investigate the relationship between P-STAT5 and other signaling pathways?

Investigating the relationship between phosphorylated STAT5 and other signaling pathways requires multi-faceted experimental approaches:

• Inhibitor Studies:

  • Use specific inhibitors targeting various signaling nodes (e.g., JAK, PI3K, MAPK inhibitors)

  • Monitor changes in STAT5 S726/S731 phosphorylation using phospho-specific antibodies

  • Example: STAT5 inhibitors have been shown to affect NPM1 levels, revealing a regulatory relationship

• Co-immunoprecipitation:

  • Immunoprecipitate with Phospho-STAT5A/B (S726/S731) antibody

  • Probe for interacting proteins from other pathways

  • Alternatively, immunoprecipitate with antibodies against proteins in other pathways and probe for phosphorylated STAT5

• Phosphoproteomic Analysis:

  • Use mass spectrometry to identify changes in the global phosphoproteome following STAT5 activation or inhibition

  • Identify co-regulated phosphorylation sites in other signaling proteins

• Genetic Manipulation:

  • Use CRISPR/Cas9 or RNA interference to modify key components of other pathways

  • Examine effects on STAT5 phosphorylation status

  • The Y740/743F, S731A, and S731A/Y740/743F STAT5B mutants provide valuable tools for such studies

• Cross-pathway Activation Studies:

  • Stimulate cells with cytokines/growth factors that activate STAT5 (e.g., IL-3, GM-CSF)

  • Monitor activation of other pathways, such as PI3K-Akt, which STAT5 can influence in the cytoplasm

  • Research has shown that STAT5 contributes to PI3K-Akt activation, highlighting its role beyond transcriptional regulation

These approaches can reveal how STAT5 phosphorylation interacts with other signaling networks to regulate cellular functions in normal and disease states.

What specialized techniques can maximize detection sensitivity for phosphorylated STAT5A/B?

To maximize detection sensitivity for phosphorylated STAT5A/B in research applications:

• Signal Amplification Methods:

  • Use high-sensitivity ECL substrates for Western blotting

  • Consider tyramide signal amplification for immunohistochemistry

  • For flow cytometry, employ fluorescent-conjugated secondary antibodies with bright fluorophores

• Phosphorylation Preservation:

  • Add phosphatase inhibitors immediately during cell lysis (e.g., sodium orthovanadate, sodium fluoride, calyculin A)

  • Use 100 nM Calyculin A treatment (30 minutes) on cells before lysis to enhance S726/S731 phosphorylation detection

  • Maintain samples at 4°C throughout processing

• Sample Enrichment:

  • Use phospho-protein enrichment columns before Western blotting

  • Consider immunoprecipitation to concentrate phosphorylated STAT5 before detection

  • For mass spectrometry applications, use titanium dioxide or immobilized metal affinity chromatography

• Optimized Stimulation Conditions:

  • For S726/S731 phosphorylation, GM-CSF treatment of TF-1 cells provides a reliable positive control

  • For cancer cell lines like SKBr3, EGF stimulation enhances S731 phosphorylation

  • Optimize stimulation time (phosphorylation peaks at different times for different stimuli)

• Advanced Imaging Techniques:

  • For cellular imaging, use super-resolution microscopy techniques like STED

  • Confocal microscopy with spectral unmixing can improve signal-to-noise ratio

  • Proximity ligation assay can detect interactions between phosphorylated STAT5 and other proteins with high sensitivity

By implementing these specialized techniques, researchers can significantly improve the detection sensitivity for phosphorylated STAT5A/B, enabling more precise analysis of signaling events even when phosphorylation levels are low.